Sale of Bosnia's Bosnalijek is postponed until autumn
This article was originally published in Scrip
Executive Summary
The Bosnian government has postponed the sale of its 19% stake (1.5 million shares) in Bosnalijek, the country's largest pharmaceutical manufacturer, until after the general elections scheduled for 3 October. It invited bids for purchasing the stake in a single transaction at the Sarajevo Stock Exchange in May with a view to sell it this month.